Neoadjuvant Oncogene-Targeted Therapy in Early Stage Non-Small-Cell Lung Cancer as a Strategy to Improve Clinical Outcome and Identify Early Mechanisms of Resistance.
McCoach, Caroline E
Neoadjuvant Oncogene-Targeted Therapy in Early Stage Non-Small-Cell Lung Cancer as a Strategy to Improve Clinical Outcome and Identify Early Mechanisms of Resistance. [electronic resource] - Clinical lung cancer 09 2016 - 466-469 p. digital
Publication Type: Journal Article
1938-0690
10.1016/j.cllc.2016.05.025 doi
Antineoplastic Agents--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials as Topic--methods
Disease Progression
Drug Resistance, Neoplasm
Humans
Lung Neoplasms--drug therapy
Molecular Targeted Therapy
Neoadjuvant Therapy
Neoplasm Staging
Proto-Oncogene Mas
Neoadjuvant Oncogene-Targeted Therapy in Early Stage Non-Small-Cell Lung Cancer as a Strategy to Improve Clinical Outcome and Identify Early Mechanisms of Resistance. [electronic resource] - Clinical lung cancer 09 2016 - 466-469 p. digital
Publication Type: Journal Article
1938-0690
10.1016/j.cllc.2016.05.025 doi
Antineoplastic Agents--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials as Topic--methods
Disease Progression
Drug Resistance, Neoplasm
Humans
Lung Neoplasms--drug therapy
Molecular Targeted Therapy
Neoadjuvant Therapy
Neoplasm Staging
Proto-Oncogene Mas